These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5159873)

  • 1. Effects of active specific and non-specific immunotherapy on E male G2 leukemia according to the route of administration and combination of immunological stimulants.
    Amiel JL; Bĕrardet M
    Eur J Cancer (1965); 1971 Oct; 7(5):419-23. PubMed ID: 5159873
    [No Abstract]   [Full Text] [Related]  

  • 2. Active immunotherapy of mouse RC 19 and E female K1 leukaemias applied after the intravenous transplantation of the tumour cells.
    Mathé G; Pouillart P; Lapeyraque F
    Experientia; 1971 Apr; 27(4):446-7. PubMed ID: 5581118
    [No Abstract]   [Full Text] [Related]  

  • 3. [Trial of treatment of E male G 2 leukemia by a combination of chemotherapy and specific and non-specific immunotherapy].
    Amiel JL; Bérardet M
    Rev Fr Etud Clin Biol; 1969; 14(7):685-8. PubMed ID: 5354663
    [No Abstract]   [Full Text] [Related]  

  • 4. [Non specific active immunotherapy by B.C.G. in virus induced leukemia in E male G2 mice in isogenic receiptients].
    Amiel JL
    Rev Fr Etud Clin Biol; 1967 Nov; 12(9):912-4. PubMed ID: 5591341
    [No Abstract]   [Full Text] [Related]  

  • 5. Repetitive administration of BCG in prevention and treatment of spontaneous leukemia of AKR mice.
    Ungaro PC; Drake WP; Mardiney MR
    J Natl Cancer Inst; 1973 Jan; 50(1):125-8. PubMed ID: 4692859
    [No Abstract]   [Full Text] [Related]  

  • 6. Active immunotherapy of AkR mice spontaneous leukemia.
    Mathé G; Halle-Pannenko O; Bourut C
    Rev Eur Etud Clin Biol; 1972 Dec; 17(10):997-1000. PubMed ID: 4660002
    [No Abstract]   [Full Text] [Related]  

  • 7. [BCG and experimental leukemia].
    Amiel JL; Berardet M
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):701-14. PubMed ID: 4559236
    [No Abstract]   [Full Text] [Related]  

  • 8. Active specific immunotherapy of murine leukemia. I. Irradiated tumor cell vaccine.
    Bartlett GL; Kreider JW; Purnell DM
    Int J Cancer; 1979 Nov; 24(5):629-35. PubMed ID: 528078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discussion paper: effect of hemolytic streptococci on lymphocytic leukemia in AKR mice.
    Havas HF
    Ann N Y Acad Sci; 1976; 277(00):299-301. PubMed ID: 1069550
    [No Abstract]   [Full Text] [Related]  

  • 10. Factor time for active immunotherapy after cytoreductive chemotherapy.
    Amiel JL; Berardet M
    Eur J Cancer (1965); 1974 Feb; 10(2):89-91. PubMed ID: 4611771
    [No Abstract]   [Full Text] [Related]  

  • 11. The antileukemic effect of systemic non-specific BCG-immunostimulation vs systemic specific immunostimulation with irradiated isogeneic leukemic cells.
    Olsson L; Ebbesen P; Kiger N; Florentin I; Mathé G
    Eur J Cancer (1965); 1978 Apr; 14(4):355-62. PubMed ID: 348478
    [No Abstract]   [Full Text] [Related]  

  • 12. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
    Mathé G; Weiner R; Pouillart P; Schwarzenberg L; Jasmin C; Schneider M; Hayat M; Amiel JL; de Vassal F; Rosenfeld C
    Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314
    [No Abstract]   [Full Text] [Related]  

  • 13. Active, specific immunotherapy of murine leukemia. II. Adjuvant effect of Corynebacterium parvum.
    Bartlett GL; Kreider JW
    Int J Cancer; 1979 Nov; 24(5):636-43. PubMed ID: 528079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active immunotherapy in the treatment of experimental leukemias and acute lymphoblastic leukemia in man.
    Mathé G; Hayat M; Amiel JL; Schwarzenberg L; Schneider M; Pouillart P; Cattan A
    Boll Ist Sieroter Milan; 1971; 50(4):251-9. PubMed ID: 5293498
    [No Abstract]   [Full Text] [Related]  

  • 15. L2C leukemia: a model of human acute leukemia.
    Murphy SG; LoBuglio AF
    Fed Proc; 1977 Aug; 36(9):2281-5. PubMed ID: 328309
    [No Abstract]   [Full Text] [Related]  

  • 16. BCG-immunotherapy of L2C-guinea pig leukemia.
    Dopatka HD; Majer M; Freudenstein H
    Eur J Cancer (1965); 1978 Feb; 14(2):169-81. PubMed ID: 624313
    [No Abstract]   [Full Text] [Related]  

  • 17. [Attempts at active non-specific immunotherapy using formolized Corynebacterium parvum].
    Amiel JL; Litwin J; Bérardet M
    Rev Fr Etud Clin Biol; 1969 Nov; 14(9):909-12. PubMed ID: 5365728
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of dose and route of Bacillus Calmette-Guérin in chemoimmunostimulation therapy of a murine leukemia.
    Pearson JW; Chaparas SD; Chirigos MA
    Cancer Res; 1973 Aug; 33(8):1845-8. PubMed ID: 4720796
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunological intervention in neoplasia.
    Weiss DW
    Johns Hopkins Med J Suppl; 1974; 3():131-56. PubMed ID: 4371312
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunoadjuvant treatment of primary grafted and spontaneous AKR-leukemia. I. Treatment efficiency correlated to autoimmune reactivity.
    Olsson L; Ebbesen P
    J Immunol; 1979 Mar; 122(3):772-80. PubMed ID: 376705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.